Show
Sort by
-
- Journal Article
- A1
- open access
Synthesis of C-5" and C-6"-modified α-GalCer analogues as iNKT-cell agonists
-
- Journal Article
- A1
- open access
Lipid and carbohydrate modifications of α-galactosylcer-amide differently influence mouse and human type I natural killer T cell activation
-
- PhD Thesis
- open access
Synthesis of new α-GalCer analogues as iNKT cell targeting agents
(2013) -
- Journal Article
- A1
- open access
Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids
-
- Conference Paper
- C3
- open access
Versatile synthesis of C-5" and C-6"-modified α-GalCer analogues as new iNKT cell ligands
-
- Journal Article
- A1
- open access
Synthesis of 6”-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands
-
Divergent synthetic approach to 6''-modified α-GalCer analogues
-
Galactose modified iNKT cell agonists stabilised by a novel structural modification of CD1D lead to marked TH1 polarisation in vivo
-
6''-Modified alpha-GalCer analogs capable of establishing an extra interaction with Cd1d leading to a polarized Th1 response and superior tumor protection
-
Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis